Friday, March 27, 2020

FDA fleshes out emergency guidance for coronavirus test developers

On Wednesday, the FDA held a webinar to flesh out its evolving policies, providing key insights on regulatory paths for molecular and serological diagnostic testing in commercial and state labs, and for commercial test products and devices.

No comments: